Fludarabine inhibits type I interferon-induced expression of the SARS-CoV-2 receptor angiotensin-converting enzyme 2
Open Access
- 31 May 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Cellular & Molecular Immunology
- Vol. 18 (7), 1829-1831
- https://doi.org/10.1038/s41423-021-00698-5
Abstract
No abstract availableFunding Information
- Natural Science Foundation of Zhejiang Province (LY19H150007)
- National Natural Science Foundation of China (81971871, 81901941, 2017YFC1310604)
This publication has 11 references indexed in Scilit:
- Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2PLOS ONE, 2020
- A virus-induced conformational switch of STAT1-STAT2 dimers boosts antiviral defensesCell Research, 2020
- Increasing host cellular receptor—angiotensin‐converting enzyme 2 expression by coronavirus may facilitate 2019‐nCoV (or SARS‐CoV‐2) infectionJournal of Medical Virology, 2020
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across TissuesCell, 2020
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2Cell, 2020
- Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral ActivityCell, 2017
- JAK-STAT Signaling: From Interferons to CytokinesOnline Journal of Public Health Informatics, 2007
- A Road Map for Those Who Don't Know JAK-STATScience, 2002
- Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signalingNature Medicine, 1999